Abstract
We have designed new non-peptidic potential inhibitors of γ-secretase and examined their ability to prevent production of amyloid-β 40 (Aβ40) and Aβ42 by human cells expressing wild-type and Swedish-mutant β-amyloid precursor protein (βAPP). Here we identify three such agents that markedly reduce recovery of both Aβ40 and Aβ42 produced by both cell lines, and increase that of C99 and C83, the carboxy-terminal fragments of βAPP that are derived from β-and α-secretase, respectively. Furthermore, we show that these inhibitors do not affect endoproteolysis of endogenous or overexpressed presenilins. These inhibitors are totally unable to affect the mΔEnotch-1 cleavage that leads to generation of the Notch intracellular domain (NICD). These represent the first non-peptidic inhibitors that are able to prevent γ-secretase cleavage of βAPP without affecting processing of mΔEnotch-1 or endoproteolysis of presenilins. The distinction between these two proteolytic events, which are both prevented by disruption of presenilin genes, indicates that although they are intimately linked with βAPP and Notch maturation, presenilins are probably involved in the control of maturation processes upstream of enzymes that cleave γ-secretase and Notch.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vassar, R. & Citron, M. Neuron 27, 419–422 (2000).
De Strooper, B et al. Nature 391, 387–390 (1998).
Herreman, A. et al. Nature Cell Biol. 2, 461–462 (2000).
Zhang, Z. et al. Nature Cell Biol. 2, 463–465 (2000).
Shen, J. et al. Cell 89, 629–639 (1997).
Davis, J. A. et al. Neuron 20, 603–609 (1998).
Donoviel, D. B. et al. Genes Dev. 13, 2801–2810 (1999).
Artavanis-Tsakonas, S., Matsuno, K. & Fortini, M. E. Science 268, 225–232 (1995).
Schroeter, E. H., Kisslinger, J. A. & Kopan, R. Nature 28, 382–386 (1998).
De Strooper, B. et al. Nature 398, 518–522 (1999).
Checler, F. Mol. Neurobiol. 19, 255–265 (1999).
Wolfe, M. S. et al. Nature 398, 513–517 (1999).
Li, Y-M. et al. Proc. Natl Acad. Sci. USA 97, 6138–6143 (2000).
Li, Y-M. et al. Nature 405, 689–694 (2000).
Esler, W. P. et al. Nature Cell Biol. 2, 428–434 (2000).
Seiffer, D. et al. J. Biol. Chem. 275, 34086–34091 (2000).
Christie, G. et al. J. Neurochem. 73, 195–204 (1999).
Citron, M. et al. Neuron 17, 171–179 (1996).
Nakajima, K., Powers, J. C., Ashe, B. M. & Zimmerman, M. J. Biol. Chem. 254, 4027–4032 (1979).
Barelli, H. et al. Mol. Med. 3, 695–707 (1997).
Ancolio, C. et al. Proc. Natl Acad. Sci. USA 96, 4119–4124 (1999).
Wolfe, M. S. J. Med. Chem. 41, 6–9 (1998).
Kopan, R., Schroeter, E. H., Weintraub, H. & Nye, J. S. Proc. Natl Acad. Sci. USA 93, 1683–1688 (1996).
Ray, W. J. J. Biol. Chem. 274, 36801–36807 (1999).
Yu, G. J. Biol. Chem. 275, 27348–27353 (2000).
Berezovska, O. et al. J. Neurochem. 75, 583–593 (2000).
Higaki, J., Quon, D., Zhong, Z. & Cordell, B. Neuron 14, 651–659 (1995).
Citron, M. et al. Proc. Natl Acad. Sci. USA 93, 13170–13175 (1996).
Capell, A. et al. J. Biol. Chem. 275, 30849–30854 (2000).
Steiner, H. et al. Biochemistry 38, 14600–14605 (1999).
Acknowledgements
We thank M. Delaage and C. Henderson for JLK inhibitors, R. Kopan for mΔENotch-1 and NICD constructs, and the following for antibodies: T. Hartmann and K. Beyreuther for WO2, M. Goedert for BR188, L. Pradier for 9E10, M. Savage for 207, D. Schenk for 10D5C, and T. Tabira and W. Araki for Ab111, Ab333 and Ab444.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Petit, A., Bihel, F., da Costa, C. et al. New protease inhibitors prevent γ-secretase-mediated production of Aβ40/42 without affecting Notch cleavage. Nat Cell Biol 3, 507–511 (2001). https://doi.org/10.1038/35074581
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/35074581
This article is cited by
-
The Flavonoid Derivative 2-(4′ Benzyloxyphenyl)-3-hydroxy-chromen-4-one Protects Against Aβ42-Induced Neurodegeneration in Transgenic Drosophila: Insights from In Silico and In Vivo Studies
Neurotoxicity Research (2014)
-
BACE and γ-Secretase Characterization and Their Sorting as Therapeutic Targets to Reduce Amyloidogenesis
Neurochemical Research (2010)
-
Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer's disease mutants
BMC Neuroscience (2008)
-
At the frontline of Alzheimer’s disease treatment: γ-secretase inhibitor/modulator mechanism
Naunyn-Schmiedeberg's Archives of Pharmacology (2008)
-
TMP21 is a presenilin complex component that modulates γ-secretase but not ɛ-secretase activity
Nature (2006)